MedPath

PHARMANET

🇵🇰Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

Phase 2
Terminated
Conditions
Peritumoral Brain Edema
PRIMARY MALIGNANT and METASTATIC BRAIN TUMORS
First Posted Date
2008-06-05
Last Posted Date
2009-01-09
Lead Sponsor
PharmaNet
Target Recruit Count
60
Registration Number
NCT00691522
© Copyright 2025. All Rights Reserved by MedPath